Dhaka: Executive Development Program on BASEL-III implementation in Islami Bank Bangladesh Limited held at Mohammad Younus Auditorium of the Bank on Saturday, reports in press release. Mohammad Abdul Mannan, Managing Director of the Bank, addressed the program as chief guest. Presided over by Md. Abdul Jabbar, Executive Vice President and Head of Risk Management Wing of the Bank, Chowdhury Md. Feroz Bin Alam, General Manager and Dipti Rani Hazra, Joint Director, Banking Regulation and Policy Department of Bangladesh Bank presented key note papers on BASEL-III and BASEL-II respectively in the program. Muhammad Abul Bashar, Md. Habibur Rahman Bhuiyan, FCA, Md. Mahbub-ul-Alam Deputy Managing Directors along with top executives of the Bank were present in the program attended by executives and officials from Head office, different Zones and Branches of the Bank. Mohammad Abdul Mannan as chief guest said, accountability, discipline and confidence have been established in the Banking sector through implementation of BASEL policies. He said that Islami Bank is liable to its entire people. The Bank keeps its competency in implementing BASEL policies. He called upon the executives to play pioneering role in the Banking sector in compliance of BASEL policies by pursuing expertise on it. The Mission of IBBL is to provide high-quality bio specimens and associated data, foster scientific excellence, catalyse partnerships and support research that translates scientific discoveries into new healthcare solutions. Vision of IBBL is to be an international centre of excellence in biobanking and to accelerate the use of personalised healthcare for the benefit of Luxembourg. Vision of IBBL is to accomplish our aims; we have identified a series of strategic goals for the immediate future: Vision of IBBL is to establish all of the necessary core activities for biobanking in Luxembourg
Vision of IBBL is to enhance the technological services available to the research community, to support the four priority research programmes in the personalised medicine initiative in Luxembourg (Cancer, Diabetes, Parkinson’s Disease, and a Normal Population Cohort), to seek partnership opportunities in all areas of its activities, to read more about the steps we have made towards accomplishing our goals, and how we intend to move forward into the future, take a look at Our History and Annual Report.